129773932891875000_25BOXlight: driven by technology and product innovations at home and abroad dual channel expansion Po Te 300,246 machinery industry research institutes: shenyin wanguo securities analyst: Li writing date: 2012-03-27 investment: increased investment in medical institutions, including monitors, medical electronic industry in China usher in a golden period of development. Ease the medical supplyConflict is the only way of continuing to increase investment in medical requirements, we expect the "Twelve-Five" period of 4.79 million from the end of 2010 the number of beds in medical institutions increased to 7.21 million
tera gold, CAGR=8.5%, and the number of beds in basic medical institutions will be maintaining a compound growth rate of 12%. New, expansion and upgrading of medical institutions, equipment replacement needs will boost medicalRapid growth of investment in electronic equipment, in particular the preference for domestic equipment purchases, we expect that the Chinese medical electronics industry growth rate can reach above 20%.
Upgrading import substitution industries is the main melody of the medical electronics industry in China, is the first breakthrough of monitor. As the core technology breakthrough, China's rapid upgrading of medical electronic equipment industry, competitive advantage and gradually established, while at theProducts
tera power leveling, markets two dimensions from the beginning to implement import substitution with foreign brands, and $ 1.1 million level of medical monitors primary breakthrough was import substitution. We believe that in the case of policies to encourage monitoring, clinical fees approved, both major hospitals and in the primary health care sector, are willing, motivated and gradually moving to price/performance advantages highlighted in high-endDomestic monitors. Technical innovation to improve product structure domestic and foreign channels with two-wheel-drive. Bao Wright depending on brand and technology innovation, constantly enrich product lines, achieving differentiation (plug-in type, such as monitors, mobile intensive care), now has a domestic manufacturer in the most complete series of monitor. Our leading products have been certified by FDA CE SFDA,We are optimistic about the company as a domestic brands in the domestic and global market expansion.
As a small market capitalisation of companies with competitive advantages, we are optimistic about BOXlight in fast-growing industries rely on technical innovation of marketing channel expansion achieved in fast-growing, is expected in the next three years the company revenue compound growth rates of up to 32%. Cover for the first time "overweight" rating. We forecast2011-2014 EPS=0.83/1.10/1.49/2.01, CAGR=34%. Corresponding to the current share price of 2012 P/E=27 times. We are optimistic about China's import substitution and the trend of globalization of medical electronics starting from the medical monitor, BOXlight as domestic monitor series, technology and product innovationCompany, given for the first time "overweight" rating.
����(Li shenyin wanguo securities) var selfURL= "http://quotes.cnfol.com/block/7039"; Online statement Gold: gold online reprint of the above content
tera gold, does not indicate that confirm the description, for investors ' reference only and does not constitute investmentRecommended. Investor operations accordingly, at your own risk.
Others:
没有评论:
发表评论